-
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9926)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2016 (publication date) through Mar 27, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7625-7644 [PMID: 27678347 DOI: 10.3748/wjg.v22.i34.7625] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i34/7625.htm |
| Number | Citing Articles |
| 1 |
Eirini Theodoraki, Eleni Orfanoudaki, Eleni Petroulaki, Kalliopi Foteinogiannopoulou, Ioannis E. Koutroubakis. Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2023; 35(1): 15 doi: 10.1097/MEG.0000000000002445
|
| 2 |
Engy Refaie, Sandra García Mateo, Samuel Jesús Martínez Domínguez, Carla Jerusalén Gargallo-Puyuelo, Laura Lario Quilez, Patricia Carrera-Lasfuentes, María Teresa Arroyo Villarino, Fernando Gomollón García. Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 2022; 45(2): 114 doi: 10.1016/j.gastre.2021.03.012
|
| 3 |
Rajesh K. Joshi, Sandeep R. Pai, Hemavathy Nagarajan, Umashankar Vetrivel. Identification of potentially bioactive compounds from Blumea lacera essential oil by gas chromatography-mass spectroscopy and molecular docking studies for targeting inflammatory bowel disease. Natural Product Research 2022; : 1 doi: 10.1080/14786419.2021.2025368
|
| 4 |
Engy Refaie, Sandra García Mateo, Samuel Jesús Martínez Domínguez, Carla Jerusalén Gargallo-Puyuelo, Laura Lario Quilez, Patricia Carrera-Lasfuentes, María Teresa Arroyo Villarino, Fernando Gomollón García. Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease. Gastroenterología y Hepatología 2022; 45(2): 114 doi: 10.1016/j.gastrohep.2021.03.012
|
| 5 |
Dorota Skrzypczak, Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Agnieszka Dobrowolska, Piotr Eder, Iwona Krela-Kaźmierczak. A Vicious Cycle of Osteosarcopenia in Inflammatory Bowel Diseases—Aetiology, Clinical Implications and Therapeutic Perspectives. Nutrients 2021; 13(2): 293 doi: 10.3390/nu13020293
|
| 6 |
Hilary K. Michel, Sandra C. Kim, Nalyn Siripong, Robert B. Noll. Gaps Exist in the Comprehensive Care of Children with Inflammatory Bowel Diseases. The Journal of Pediatrics 2020; 224: 94 doi: 10.1016/j.jpeds.2020.04.002
|
| 7 |
Daniela Marotto, Fabiola Atzeni, Sandro Ardizzone, Giovanni Monteleone, Valeria Giorgi, Piercarlo Sarzi-Puttini. Extra-intestinal manifestations of inflammatory bowel diseases. Pharmacological Research 2020; 161: 105206 doi: 10.1016/j.phrs.2020.105206
|
| 8 |
Sharmila S Prasad, Michael Potter, Simon Keely, Nicholas J Talley, Marjorie M Walker, Therése Kairuz. Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: A systematic review. JGH Open 2020; 4(2): 221 doi: 10.1002/jgh3.12235
|
| 9 |
Gráinne H. Long, Amanda R. Tatro, Young S. Oh, Sheila R. Reddy, Ashwin N. Ananthakrishnan. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data. Advances in Therapy 2019; 36(11): 3079 doi: 10.1007/s12325-019-01095-1
|
| 10 |
Reid L. Hopkins, Jamie Abbott, Debjani Sahni, Francis A. Farraye. Cancer Screening in Inflammatory Bowel Disease. 2019; : 33 doi: 10.1007/978-3-030-15301-4_3
|
| 11 |
Leandro Lopes Troncoso, Ana Luiza Biancardi, Haroldo Vieira de Moraes Jr, Cyrla Zaltman. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World Journal of Gastroenterology 2017; 23(32): 5836-5848 doi: 10.3748/wjg.v23.i32.5836
|
| 12 |
M. Nedim Ince, David E. Elliott. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel Diseases. Gastroenterology Clinics of North America 2019; 48(2): 237 doi: 10.1016/j.gtc.2019.02.006
|
| 13 |
Anna Deskur, Iwona Zawada, Wojciech Błogowski, Teresa Starzyńska. Cerebral venous sinus thrombosis in a young patient with ulcerative colitis. Medicine 2019; 98(41): e17428 doi: 10.1097/MD.0000000000017428
|
| 14 |
Lidan Linda Zhong, Wai Ching Lam, Hei Lam Helena Cheung, Aiping Lyu. Allergic and Immunologic Diseases. 2022; : 1325 doi: 10.1016/B978-0-323-95061-9.00047-3
|
| 15 |
Ioana Păunică. Diagnostic and treatment difficulties in Crohn’s disease. Journal of Clinical and Investigative Surgery 2016; 1(2): 47 doi: 10.25083/2559.5555.12.713
|
| 16 |
Ewa Waszczuk, Karolina Waszczuk, Anna Bohdanowicz-Pawlak, Jerzy Florjański. Women with inflammatory bowel diseases have a suboptimal cervical cancer screening rate and are not aware of the recommended human papilloma virus vaccine. Gynecological Endocrinology 2018; 34(8): 656 doi: 10.1080/09513590.2017.1416466
|
| 17 |
Catherine Colquhoun, Michelle Duncan, George Grant. Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis. Diseases 2020; 8(2): 13 doi: 10.3390/diseases8020013
|
| 18 |
Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Anna Maria Rychter, Agnieszka Zawada, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak. Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2021; 10(7): 1515 doi: 10.3390/jcm10071515
|
| 19 |
Isabel Roitman, Anjali Mone, Arun Swaminath. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 171 doi: 10.1007/978-3-030-81780-0_7
|
| 20 |
Bárbara B. Colombo, Victor Fattori, Carla F. S. Guazelli, Tiago H. Zaninelli, Thacyana T. Carvalho, Camila R. Ferraz, Allan J. C. Bussmann, Kenji W. Ruiz-Miyazawa, Marcela M. Baracat, Rúbia Casagrande, Waldiceu A. Verri. Vinpocetine Ameliorates Acetic Acid-Induced Colitis by Inhibiting NF-κB Activation in Mice. Inflammation 2018; 41(4): 1276 doi: 10.1007/s10753-018-0776-9
|
| 21 |
Fang Xu, James M. Dahlhamer, Emily P. Terlizzi, Anne G. Wheaton, Janet B. Croft. Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015–2016. Digestive Diseases and Sciences 2019; 64(7): 1798 doi: 10.1007/s10620-019-05494-w
|
| 22 |
Lauren Sahakian, Rhiannon T Filippone, Rhian Stavely, Ainsley M Robinson, Xu Sean Yan, Raquel Abalo, Rajaraman Eri, Joel C Bornstein, Mark R Kelley, Kulmira Nurgali. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis. Inflammatory Bowel Diseases 2021; 27(3): 388 doi: 10.1093/ibd/izaa161
|
| 23 |
Sharmila S. Prasad, Kerith Duncanson, Simon Keely, Nicholas J. Talley, Therése Kairuz, Gerald J. Holtmann, Ayesha Shah, Marjorie M. Walker. A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review. Pharmacy 2020; 8(4): 204 doi: 10.3390/pharmacy8040204
|
| 24 |
Salwa M. El-sayed, Mona I. Nossier, Ahmed Ibrahim Nossier. Faba beans with enhanced antioxidant activity ameliorate acetic acid-induced colitis in experimental rats. Food & Function 2022; 13(22): 11865 doi: 10.1039/D2FO02782H
|
| 25 |
Mohamed A. Morsy, Hanaa M. Khalaf, Rehab A. Rifaai, Asmaa M.A. Bayoumi, Esraa M.M.A. Khalifa, Yasmine F. Ibrahim. Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. Biomedicine & Pharmacotherapy 2021; 141: 111902 doi: 10.1016/j.biopha.2021.111902
|
| 26 |
Matthew D Egberg, Ajay S Gulati, Ziad F Gellad, Gil Y Melmed, Michael D Kappelman. Improving Quality in the Care of Patients with Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2018; 24(8): 1660 doi: 10.1093/ibd/izy030
|
| 27 |
Andrew D. Spence, Mais Khasawneh, Patrick B. Allen, Jennifer Addley. Communication of alcohol and smoking lifestyle advice to the gastroenterological patient. Best Practice & Research Clinical Gastroenterology 2017; 31(5): 597 doi: 10.1016/j.bpg.2017.09.014
|